Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert H Getzenberg

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Expert Opinion on Medical Diagnostics|March 16, 2013
Urinary protein biomarkers of cancerBrian Keith McNeil, Robert H Getzenberg
BJU International|February 23, 2008
Urine-based markers in bladder cancer: future prospectsBrian K McNeil, Robert H Getzenberg
Current Urology Reports|September 4, 2008
Biomarkers for benign prostatic hyperplasia progressionGrant W Cannon, Robert H Getzenberg
Journal of Cellular Biochemistry|April 25, 2007
Nuclear structure as a source of cancer specific biomarkersEddy S Leman, Robert H Getzenberg
Journal of Cellular Biochemistry|June 10, 2009
Biomarkers for prostate cancerEddy S Leman, Robert H Getzenberg
Journal of Cellular Biochemistry|December 23, 2003
Fingerprinting the diseased prostate: associations between BPH and prostate cancerUzma S Shah, Robert H Getzenberg
The Journal of Urology|June 11, 2005
Benign prostatic hyperplasia cell line viability and modulation of jm-27 by doxazosin and IbuprofenCynthia H Minnery, Robert H Getzenberg
Urology|March 29, 2006
Urinary matrix metalloproteinase activity is not significantly altered in patients with renal cell carcinomaGlenn M Cannon, Robert H Getzenberg
Journal of Cellular Biochemistry|January 18, 2003
Effects of 1,25-dihydroxyvitamin D3 on the distribution of androgen and vitamin D receptors in human prostate neonatal epithelial cellsEddy S Leman, Robert H Getzenberg
Molecular Pharmaceutics|September 17, 2011
Changing the energy habitat of the cancer cell in order to impact therapeutic resistanceRobert H Getzenberg, Donald S Coffey
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Expert Opinion on Medical Diagnostics|March 16, 2013
Urinary protein biomarkers of cancerBrian Keith McNeil, Robert H Getzenberg
BJU International|February 23, 2008
Urine-based markers in bladder cancer: future prospectsBrian K McNeil, Robert H Getzenberg
Current Urology Reports|September 4, 2008
Biomarkers for benign prostatic hyperplasia progressionGrant W Cannon, Robert H Getzenberg
Journal of Cellular Biochemistry|April 25, 2007
Nuclear structure as a source of cancer specific biomarkersEddy S Leman, Robert H Getzenberg
Journal of Cellular Biochemistry|June 10, 2009
Biomarkers for prostate cancerEddy S Leman, Robert H Getzenberg
Journal of Cellular Biochemistry|December 23, 2003
Fingerprinting the diseased prostate: associations between BPH and prostate cancerUzma S Shah, Robert H Getzenberg
The Journal of Urology|June 11, 2005
Benign prostatic hyperplasia cell line viability and modulation of jm-27 by doxazosin and IbuprofenCynthia H Minnery, Robert H Getzenberg
Urology|March 29, 2006
Urinary matrix metalloproteinase activity is not significantly altered in patients with renal cell carcinomaGlenn M Cannon, Robert H Getzenberg
Journal of Cellular Biochemistry|January 18, 2003
Effects of 1,25-dihydroxyvitamin D3 on the distribution of androgen and vitamin D receptors in human prostate neonatal epithelial cellsEddy S Leman, Robert H Getzenberg
Molecular Pharmaceutics|September 17, 2011
Changing the energy habitat of the cancer cell in order to impact therapeutic resistanceRobert H Getzenberg, Donald S Coffey
Pageof 12